Adequate energy storage is essential for sustaining healthy life. Lipid droplet (LD) is the subcellular organelle that stores energy in the form of neutral lipids and releases fatty acids under energy deficient conditions. Energy storage capacity of LDs is primarily dependent on the sizes of LDs. Enlargement and growth of LDs is controlled by two molecular pathways: neutral lipid synthesis and atypical LD fusion. Shrinkage of LDs is mediated by the degradation of neutral lipids under energy demanding conditions and is controlled by neutral cytosolic lipases and lysosomal acidic lipases. In this review, we summarize recent progress regarding the regulatory pathways and molecular mechanisms that control the sizes and the energy storage capacity of LDs. 
INTRODUCTION
Energy is essential for life as it can be converted to ATP to perform meaningful work at an acceptable metabolic cost in healthy organism. Food, the major chemical source of energy, is digested and absorbed through the digestive system. Part of the energy is stored in cells and can be transformed and utilized to sustain life under starvation, prolonged physical activity and stress conditions. Glycogen and triacylglycerol (TAGs, neutral lipids or fat) are the two major forms of stored energy in the body. Glycogen is mainly stored in the liver and muscle. TAG, the most efficient form of energy due to its high energy density and the hydrophobic characteristics, is mainly stored in the adipose tissue, whereas small amounts are found in the liver and muscle (Herman, 2016) . The amount of stored energy represents the balance between energy intake and energy expenditure. *Corresponding author (email: li-peng@tsinghua.edu.cn) The subcellular organelle responsible for lipid storage is lipid droplet (LD) that is present in most organisms and cell types (Murphy, 2012) . Adipose tissue is the main tissue responsible for lipid storage in higher animals. Mammals mainly possess two types of adipose tissue: white and brown adipose tissue (WAT and BAT, respectively) . White adipocyte contains a unilocular LD and is the major lipid storage cell in the body. LD stores excess energy in the form of TAG and releases free fatty acids (FFAs) by TAG degradation. Besides being actively involved in lipid storage and lipid homeostasis, LDs are highly dynamic in the cell by interacting with many other subcellular organelles including endoplasmic reticulum (ER), mitochondria, lysosome, endosome and autophagosome (Barbosa et al., 2015; Beller et al., 2010; Fujimoto and Parton, 2011; Murphy et al., 2009; Welte, 2015; Zehmer et al., 2009) . The lipid storage capacity of LDs is determined by its "size" (the volume) and controlled by the balance beween TAG synthesis and degradation, and also CIDE (cell death-inducing DFFA (DNA fragmentation factor, alpha subunit)-like effector) family proteins mediated atypical LD fusion. Net increase of cellular or localized TAG synthesis or CIDE mediated atypical LD fusion promotes LD growth and expansion. On the contrary, TAG degradation via cytosol or lysosomal lipase results in the reduction of LD sizes and lower lipid storage capacity. Regulation of LD sizes and lipid storage capacity is important in maintaining normal biological function especially under starvation and stress conditions. Its deregulation results in the development of metabolic diseases including obesity, diabetes, fatty liver, cardiovascular disease, neurodegenerative disease and cancer (Filipe and McLauchlan, 2015; Gong et al., 2009; Gross and Silver, 2014; Krahmer et al., 2013; Liu et al., 2015; Rutkowski et al., 2015; Saka and Valdivia, 2012; Suzuki et al., 2011; Xu et al., 2012) . This review summarizes the structure and function of LDs and the main regulatory pathways and molecular mechanism that control the sizes of LDs and the lipid storage capacity.
THE STRUCTURE AND FUNCTION OF LDS
LD is composed of a monolayer of phospholipids, a neutral lipid core and various associated proteins (Figure 1 ). Lipidomic analyses of isolated LDs from various cell types reveal that phosphatidylcholine (PC) is the major phospholipid, followed by phosphatidylethanolamine (PE) and phosphatidylinositol (PI). Small amount of lyso-PC and lyso-PE, ether-linked form of PC and PE and free cholesterol has also been detected in LD fraction Ohsaki et al., 2014; Tauchi-Sato et al., 2002; Walther and Farese, 2012) . Plin1 is the first LD-associated protein identified in mammalian cells. Since then, many types of LD associated proteins are identified by various proteomic and molecular analyses. Majority of the LD-associated proteins are involved in controlling LD dynamics under different nutrient conditions and hormone stimulations. The main components of neutral lipid core in most eukaryotic cells are TAG and sterol ester (SE). Ribosome, ER-like membrane and other proteins are also reported in the neutral lipid core in specific cell types (Robenek et al., 2009; Wan et al., 2007) . The actual structure or organization of the neutral lipid core remains to be elusive. FFAs released from LDs by TAG degradation can function as potential ligands for PPARs and substrates for synthesis of other signal molecules, such as endocannabinoids and prostaglandins (Zechner et al., 2012) . Neutral lipids stored in LDs also detoxify FFAs and cholesterols, and as a key reservoir of membrane components and energy, which confers selective advantages to the organisms.
In eukaryotes, LDs are generated from ER where most of enzymes for TAG synthesis are localized. Due to the physical feature, nascent LDs are budded out from ER membrane and form cytosolic LDs. However, cytosol LDs are observed to have extensive contacts with ER and LD-ER contacts may act as a conduit for the lipids and proteins exchange, and may related to ER stress and ER-assisted degradation (ERAD) of unfolded proteins (Barbosa et al., 2015; Gao and Goodman, 2015; Jacquier et al., 2011; Kassan et al., 2013; Knoblach and Rachubinski, 2015; Wilfling et al., 2014) . Mitochondria and Figure 1 The structure and function of LDs. LD is composed of a neutral lipid core, a monolayer phospholipid membrane and its associated surface proteins. The major components of neutral lipids in mammalian LD are triacylglycerols (TAGs) and sterol esters (SEs). Dysregulated LD homeostasis is closely connected to many pathological conditions and the development of various diseases reactive oxygen species (ROS). peroxisome, organelles responsible for lipid oxidation, also have close association with LDs, and Plin5 has been identified to mediate the interaction between LD and mitochondria and may facilitate the transport of FA for oxidative phosphorylation with increased energy demand (Gao and Goodman, 2015; Lodhi and Semenkovich, 2014; Mason and Watt, 2015; Pu et al., 2011; Rambold et al., 2015; Schrader, 2001; Yu et al., 2015) . LDs are also observed surrounding the nucleus or actually present in the nucleus that may function to store specific proteins or sequester transcriptional factors Welte, 2015) . The interaction between LDs and endosomes also observed and likely regulated by Rab5 (Liu et al., 2007) .
Excess or insufficient lipid storage is associated with many pathological conditions including obesity, insulin resistance, inflammation, fatty liver diseases, atherosclerosis, neurodegenerative disease, cancer development and viral replication ( Figure 1 ). As the major tissue for lipid storage, adipose tissue plays a crucial role in controlling lipid homeostasis. It protects the body from lipotoxity by transforming FFAs into TAGs, and releases glycerol and FFAs as energy resource for other tissues during energy limitation. Excessive lipid storage in adipocytes results in hypoxia, ER stress, insufficient angiogenesis, increased adipocyte death, high immune cell infiltration, increased secretion of pro-inflammatory cytokines and the development of obesity and insulin resistance (Sell et al., 2012; Ye, 2013) . On the other hand, insufficient lipid storage in adipose tissue under lipodystrophic condition leads to adipocyte lipotoxicity, mitochondrial dysfunction, increased oxidative stress, inflammatory responses, deregulated release of free fatty acids and impaired insulin sensitivity (Bindlish et al., 2015; Frayn, 2001; Grundy, 2015) .
Excess lipid storage in the form of cholesterol esters in LDs of macrophages due to the increased uptake of oxidized lowdensity lipoprotein is the major cause of foam cell formation during the development of atherosclerosis and cardiovascular disease. Higher lipid storage and increased LD sizes in leukocytes is observed under allergic inflammation and pathogen infections. Degradation of TAG from LDs in leukocytes by lipases (Dichlberger et al., 2014; Melo and Weller, 2016) liberates arachidonic acid (AA) that is further converted to prostaglandin (PG) by cyclooxygenase (COX) in response to immuno-activation. LDs are also shown to be associated with viral assembly of hepatitis C virus (HCV), dengue virus, bacterial infection, and anti-pathogen infection due to its association with Histone proteins and Viperin (Anand et al., 2012; Camus et al., 2013; Crawford and Desselberger, 2016; D'Avila et al., 2008; Filipe and McLauchlan, 2015; Hinson and Cresswell, 2009) . Most recent research has demonstrated that the size of LDs and increased lipid accumulation is associated with cancer development and neural degenerative diseases (Baenke et al., 2013; Chen and Li, 2016; Liu et al., 2015; Qiu et al., 2015) .
INCREASED LIPID STORAGE BY THE GROWTH OF LDS
The sizes of LDs vary drastically in different cell types, reflecting their varying lipid storage capacity. The diameters of LDs in most non-adipose cells range from dozens of nanometers to several micrometers. In white adipocytes that are most efficient in storing lipids, the diameters of their uniloculars LD can be easily larger than 100 µm. As unilocular large LD contains smaller surface area compared with that of multilocular smaller LDs, it is protected from lipase degradation. Potential difference in phospholipids composition of large LDs may also contribute to the higher lipid storage capacity than that of small LDs (Cohen et al., 2015) . The sizes and the volume of LDs are dependent on two major mechanisms: the growth activity of LDs that is dependent either on the activity of TAG synthesis or the atypical LD fusion that is mediated by CIDE proteins. Second, it is also dependent on the rate of TAG degradation that is controlled by cytosolic and lysosomal lipases. Growth by quick fusion of LDs through coalescence has also observed in some specific pharmacological conditions but its physiological relevance remains to be solved.
LD GROWTH BY ELEVATED TAG SYNTHESIS
As the core of LDs and the basic energy sources, the amount of TAG directly determines the size LDs and the amount of stored lipids. LD growth can occur by local synthesis of TAGs on LDs (Figure 2A ), or by transferring TAG that is synthesized on ER to LDs. TAG is generated by a chain of biochemical reactions using FA as the substrate. Cells can either uptake FA from extracellular environment or generate FA by de novo synthesis. Various fatty acid transporting proteins are responsible for FA uptake and intracellular trafficking. De novo synthesis of FA is catalyzed by a series of enzymatic reactions and regulated by key transcriptional factors such as sterol regulatory element-binding protein-1c (SREBP-1c), liver X receptor (LXR), and carbohydrate response element binding protein (ChREBP) (Ferré and Foufelle, 2010; Strable and Ntambi, 2010) .
TAG is synthesized by the addition of FA to glycerol-3 phosphate through the sequential enzymatic reactions catalyzed by glycerol-3-phosphate O-acyltransferase (GPAT), 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT), phosphatidic acid phosphatase (PAP)/lipin, and diglyceride acyltransferase (DGAT). Most of these enzymes are localized on ER where TAG is generated and transported to LDs through unknown mechanism (Kory et al., 2016) . Certain subset of enzymes (ACSL1, ACSL3, ACSL4, GPAT4, AG-PAT3, Lipin1 and DGAT2) are reported to be specifically localized to LDs and promote local TAG synthesis and LD growth (Brasaemle et al., 2004; Fujimoto et al., 2007; Khelef et al., 1998; Kuerschner et al., 2008; Liu et al., 2004; Pol et al., 2014; Poppelreuther et al., 2012; Stone et al., 2009; Valdearcos et al., 2011; Wang et al., 2011; Wilfling et al., 2013) . Growth of LD would also require phospholipids to stabilize the neutral lipid core. CTP:phosphocholine cytidylyltransferase (CCT), a rate-limiting enzyme in phospholipid synthesis pathway is responsible for the replenishment of phospholipids during the rapid growth of LDs. Newly synthesized PC may be transferred from ER to LDs by LD-ER conduit or other unknown pathways. LD growth through elevated TAG synthesis is a general mechanism for enhanced energy storage and probably reduced lipotocixity in many cell types from lower organisms such as yeast, C. elegans, fly to human (Murphy, 2012) .
LD GROWTH PROMOTED BY ATYPICAL FUSION
Cells (adipocytes, hepatocytes, sebocytes etc.) that contain large LDs and have high capacity in storing lipids have adapted a special mechanism to efficiently increase lipid storage by special form of LD fusion that is mediated by CIDE proteins. Using genetically modified animal models, we have found that CIDE family proteins (including Cidea, Cideb, and Cidec/Fsp27) are important regulators of lipid storage in the adipocytes, hepatocytes, skin sebocytes and the mammary epithelia. The development of obesity and fatty liver diseases have been positively correlated with their protein levels (Matsusue et al., 2008; Toh et al., 2008; Xu et al., 2016) . On the contrary, CIDEs deficiency leads to lipodystrophy, insulin resistance, dry skin and newborn death. In particular, white adipocytes require Cidec/Fsp27 for the formation of unilocular LD since its deficiency results in the accumulation of multilocular small LDs and markedly reduced lipid storage (Nishino et al., 2008; Rubio-Cabezas et al., 2009; Toh et al., 2008) . Reduced LD sizes and low lipid storage is also observed in Cideb deficient hepatocytes, Cidea deficient skin sebocytes, brown adipocytes and mammary epithelia cells Wang et al., 2012; Wu et al., 2014b; Zhang et al., 2014; Zhou et al., 2003) .
How do CIDE proteins promote LD growth and increase lipid storage? We have observed that these proteins are enriched and clustered at LD contact sites (LDCS) where they generate a potential pore (or channel structure) to allow lipid to exchange among contacted LD pair. The higher internal pressure in smaller LD will then drive the internal lipid transfer from the smaller LD to the large one to form a larger LD (Gong et al., 2011) . As this process is different from SNARE-mediated membrane fusion, we define this as atypical LD fusion (Figure 3) . We have further identified several proteins that interact with Cidec to promote LD fusion and unilocular LD formation in adipocytes. One of such protein is Plin1, a LD-associated protein that originally found to protect LD from lipase digestion. By interacting with the N-terminal domain of Cidec, Plin1 maintains Cidec in a correct conformation and may stabilize the Cidec fusion complex and increase the efficiency of LD fusion (Sun et al., 2013) . We also identified Rab8a as an important regulator of Cidec-mediated LD fusion. GTPase-activating proteins AS160 (Akt substrate Figure 3 Model of CIDE-mediated atypical fusion of LD that includes LD movement; enrichment of CIDEs at LD contact site (LDCS) and stabilization of CIDE protein complex by Rab8a; formation of fusion pore that is stabilized by Plin1, and initiation of lipid transfer from smaller to larger LDs that is dependent on internal pressure and other unknown factors; and the final completion of LD fusion and redistribution or recycling of CIDE protein complex. of 160 kD) and guanine nucleotide exchange factor MSS4 (mammalian suppressor of Sec4) that modulate Rab8a activity, are also important in regulating Cidec-mediated atypical LD fusion (Wu et al., 2014a) . In summary, CIDE-mediated atypical LD fusion and growth can be characterized into a few steps. First, LDs move quickly in the cell that may depend on microtubule. Second, LDs contact each other and form a tight junction with the enrichment of CIDE proteins at the contact site. This step is mediated by CIDE proteins and regulated by Rab8a. Third, fusion pore is formed and stabilized, and this step is likely dependent on Plin1 in adipocytes. Fourth, lipid transfer from smaller to larger LDs that is dependent on surface tension and internal pressure of contacted LD pairs. Finally, when fusion completed, the fusion protein complex is disassembled and CIDE proteins and its associated proteins are redistributed on the surface of LDs ( Figure  3 ). In the future, it will be interesting to identify novel factors in CIDE-mediated LD fusion, characterize the structure of the fusion complex and delineate the regulatory pathways that mediate nutrient and hormonal response in CIDE-mediated atypical LD fusion.
THE SHRINKAGE AND DEGRADATION OF LDS
Another important mechanism to regulate lipid storage and LD sizes is the degradation of TAG in the neutral lipid core by lipases to generate FFAs for providing energy substrate during increased energy demand (endurance exercise) and energy deprivation (fasting or starve). FFAs released from TAG degradation are transported intracellularly to mitochondria for oxidation and ATP generation. FFAs released from WAT enter into the circulation, and uptaken and transported by various FA binding/transporting proteins for further oxidation in muscle, heart, liver and other tissues. Glycerol, another production of TAG degradation, is released to the circulation and converted to glucose in the liver (Large et al., 2004; Zechner et al., 2009 ). There are two well-studied TAG hydrolysis pathways. First is the direct degradation of TAG by neutral lipases that binds to LDs. Another is the degradation of TAG in LDs by lysosomal acid lipase (LAL) that is localized to lysosomes. This pathway requires the delivery of LDs to lysosome by autophagosomes (Schweiger and Zechner, 2015; Singh et al., 2009 ).
LD DEGRADATION BY NEUTRAL LIPASES
Neutral cytosolic lipases responsible for TAG degradation include adipose triglyceride lipase (ATGL), hormone sensitive lipase (HSL), and monoglyceride lipase (MGL). These enzymes work step-wise to hydrolyze TAGs from LDs. ATGL catalyzes the first step of lipolysis by hydrolyzing TAG and generating FFA and DAG, DAG is successively hydrolyzed by HSL to liberate FFA and monoacylglycerol (MAG). Finally, MGL converts MAG to glycerol and FFA. ATGL has been shown to play a crucial role in animal survival, organ function, as well as cancer cell growth, and cachexia Zechner, 2015) . Human mutation of ATGL also results in neutral lipid storage disease with myopathy (Fischer et al., 2007) .
Neutral lipase-mediated LD degradation is a complex, multi-factorial process that is regulated by hormones, cytokines, adipokines and protein-protein interaction (Zechner, 2015; Zechner et al., 2009 ). The catalytic activity of ATGL is modified by its interaction with other proteins including abhydrolase domain containing 5 (ABHD5/CGI-58) and G0/G1 switch gene 2 (G0S2). Interaction with CGI-58 significantly increases the hydrolase activity of ATGL. In contrast, when ATGL interacts with G0S2, its enzymatic activity is strongly inhibited Yang et al., 2010) . Under basal condition, Plin1 forms a protective barrier on LDs, preventing lipases from accessing LDs (Brasaemle et al., 2000; Martinez-Botas et al., 2000; Tansey et al., 2001 ). Plin2 and Plin5 also play similar roles to that of Plin1 (Kimmel and Sztalryd, 2016; Mason et al., 2014; Mason and Watt, 2015; Sztalryd and Kimmel, 2014) . In addition, Plin1 interacts with CGI-58, rendering low ATGL activity in hydrolyze TAG Yamaguchi et al., 2004) . HSL is predominantly present in the cytosol and does not appear to contribute to basal lipolysis (Miyoshi et al., 2008) (Figure 4A ). MGL hydrolyzes MAG that is produced by ATGL and HSL to generate FFAs and glycerol. One interesting feature of MGL is that is has no significant substrate specificity and can be localized to LDs, ER, cytoplasm, and the plasma membrane. The activity of ATGL and MGL is also important in cancer pathogenesis (Nomura et al., 2010; Zechner, 2015) .
Catecholamines (CA) acting on β-adrenergic receptors (β-AR) is the most potent stimulatory signals for lipolysis (Lafontan and Berlan, 1993) . Activation of β-AR by CA leads to the activation of adenylate cyclase, increased cAMP levels, and subsequent activation of cAMP-dependent protein kinase-A (PKA) (Collins et al., 2004; Holm, 2003) (Figure 4B ). The most well studied PKA substrates in lipolysis are Plin1 and HSL. When Plin1 is phosphorylated by PKA, CGI-58 is released from Plin1-CGI-58 complex, leading to the association between CGI-58 and ATGL, and high TAG hydrolysis activity (Gandotra et al., 2011; Miyoshi et al., 2008; Smirnova et al., 2006; Watt and Steinberg, 2008; Zimmermann et al., 2004) (Figure 4B ). Plin5 is also a downstream target of PKA and may play a similar role in hormone-stimulated lipolysis to that of Plin1 (Macpherson et al., 2013; Pollak et al., 2015) . Phosphorylated Plin1 also recruit phosphorylated HSL to LDs and modulate its activity Figure 4 The regulation of LD degradation by cytosolic lipases under basal (A), hormone or starvation conditions (B) or LD degradation by lysosomal lipases under starvation condition (C). CA, catecholamine; β-AR, β-adrenergic receptor; Gs, stimulative regulative G-protein. (Miyoshi et al., 2006; Wang et al., 2009; Watt et al., 2006) . However, the physiological relevance of the post translational modification of ATGL in controlling lipolysis and lipid storage remains to be controversial. Recent analysis has revealed that chaperone-mediated autophagy (CMA) may cross talk with neutral lipase-mediated lipolysis by removing Plin2 and Plin3 from LD surface and triggering their degradation by lysosomes through their association with chaperone Hsc70, resulting in the translocation of ATGL to LD for TAG degradation (Kaushik and Cuervo, 2015) (Figure 4B ).
LD DEGRADATION MEDIATED BY LYSOSOMAL ACIDIC LIPASES
For a long time, lysosomal acidic lipases (LALs) are believed to be responsible for the degradation of lipid membranes and exogenous lipoproteins that are taken up by cells and delivered to lysosome. In 2009, Singh and colleagues found that under prolonged fasting condition, autophagy plays an important role in LD degradation by selective uptake and sequestering of LDs to autophagosome to deliver to lysosome for degradation (lipophagy) in the liver (Singh et al., 2009 ). Since then, lipohagy has been discovered in many cell types as well as lower organisms such as yeast and fungi (Wang, 2016) . The precise mechanism of lipophagy activation in particular how autophagosome specifically recognizes LDs is not clear and remains a hot debate. As LC3-I, LC3-II and several regulatory proteins in autophagic pathways are found to be enriched in LDs, these proteins may play a role in lipophagy activation (Singh et al., 2009) (Figure 4C ). Rab7, a small GTPase, has also shown to associate with LDs in starved hepatocytes and may be important for autophagy-mediated LD degradation (Schroeder et al., 2015) . In addition, crosstalk between autophagic-and neutral lipase-mediate LD degrada-tion has been demonstrated as PNPLA5, a lipase that is localized to LDs, is required for efficient autophagy by likely supplying FAs for phospholipid production during autophagic progression (Dupont et al., 2014) .
OTHER IMPORTANT FACTORS CONTROLLING LD SIZES AND LIPID STORAGE
In addition to the above mentioned LD growth and degradation pathways, the sizes of LDs and the intracellular lipid storage capacity are regulated by several other factors including Seipin, Pnpla3, Hsd17b13, Cavin and Ces1 (Bi et al., 2014; Cai et al., 2015; Cartwright et al., 2015; Grippa et al., 2015; Han et al., 2015; Romeo et al., 2008; Su et al., 2014; Szymanski et al., 2007; Wang et al., 2016; Wolinski et al., 2015) . Seipin is originally discovered due to its mutation in severe congenital generalized lipodystrophy (Magré et al., 2001 ). Fld1, a homolog of Seipin in yeast, controls LD sizes as its deficiency results in the accumulation of "supersized" LDs (Fei et al., 2008; Szymanski et al., 2007) . Seipin homolog in fly also plays a conserved role in controlling lipid storage and LD sizes (Tian et al., 2011) . Seipin is an ER-associated protein that may function to control localized PA production, Ca 2+ homeostasis as well as mediate ER-LD contact (Bi et al., 2014; Cartwright and Goodman, 2012; Grippa et al., 2015; Han et al., 2015; Wolinski et al., 2015) . Most recent research by Wang, et al. has indicated that Seipin forms discrete foci on ER to control nascent LD growth . Genetic or proteomic screening of human fatty liver patients leads to the identification of Pnpla3 and Hsd17b13 that are correlated with the development of liver steatosis (Chamoun et al., 2013; Romeo et al., 2008; Su et al., 2014) . Interestingly, adipocyte is one of the most caveolae-enriched cell types and loss of caveolae leads to lipodystrophic phenotype in humans. Recent analysis shows that caveolae may participate in adipocyte response to mechanotension and lipid store fluctuation (Dwianingsih et al., 2010; Shastry et al., 2010) . Regulatory factors such as PPARgamma and AKT can also regulate lipolysis and lipid storage in adipocytes .
CONCLUSION AND FUTURE PERSPECTIVES
Sustainable energy supply is critical for survival under adverse conditions such as fasting, prolonged exercise and stress. On the contrary, excess energy storage due to increased energy uptake and reduced energy expenditure results in the development of metabolic disorders including obesity, diabetes and fatty liver disease. LDs are the subcellular organelles responsible for energy storage. The sizes and number of LDs reflect the energy storage capacity and are regulated by many biological processes including localized TAG synthesis, atypical LD fusion and LD degradation mediated by neutral lipases and autophagy mediated lysosomal acidic lipases. Coordinated regulation of lipid metabolism, glucose metabolism, mitochondrial activity, FA oxidation, ER and Golgi activity are also important in regulating lipid storage. In addition, nutrient response, hormonal stimulation and other environmental factors may also contribute to the intracellular LD sizes and lipid storage.
Therapeutical strategies targeting to lipid storage pathway in controlling the development of metabolic disorders were initiated many years ago and significant progress have been made in the identification of compounds or molecules that control the activation of metabolic consumption of lipids by increasing mitochondrial FA oxidaiton, reducing lipid uptake and synthesis and enhancing lipase activity. Our in-depth understanding of the molecular mechanism of lipid storage regulation would provide novel therapeutical approaches for the development of effective tools for combating lipid storage related diseases.
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